Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.



Leading French Lab Uses Skeletal Muscle Kit to Study Duchenne Myopathy

AMSBIO reports on an independent evaluation and use by I-Stem (Corbeil-Essonnes, France) of the Skeletal Muscle Differentiation kit - a cell culture media system to differentiate human stem cells into functional myotubes.

Read the rest of entry »

FDA Advisory Committee Unanimously Recommends CTL019 (tisagenlecleucel) for Approval

Oxford BioMedica (LSE:OXB) is a leading gene and cell therapy group focused on developing life changing treatments for serious diseases. 

Read the rest of entry »

PCI Reinforces Ongoing Commitment to Serialization in Response to Delayed Enforcement of FDA Deadline

PCI Pharma Services (PCI) has affirmed its position relative to the delayed enforcement of the US Food and Drug Administration (FDA)’s Compliance Policy for ‘Product Identified Requirements Under the Drug Supply Chain Security Act' (DSCSA).

Read the rest of entry »

Price cut secures a place for Ipsen’s Cabomeytx on the NHS

Ipsen has cut the price of its kidney cancer Cabometyx to help secure its place within the NHS’ routine commissioning stream, helping to over-turn a previous decision that it did not represent value for money.

Read the rest of entry »

Oxford BioMedica signs major supply deal with Novartis

Oxford BioMedica has sealed a major deal with Novartis to supply the Swiss drug giant with lentiviral vectors used to create cell therapy products, including CTL019 and other undisclosed Chimeric Antigen Receptor T cell (CART) products.

Read the rest of entry »

Lilly victorious in Alimta patent case

Eli Lilly has welcomed a decision by the UK Supreme Court that alternative salt forms of its cancer drug Alimta.

Read the rest of entry »

Isansys’ ‘washable’ high-tech patient sensors feature in the Government’s latest Great Britain campaign

Isansys Lifecare is delighted to announce that we have been chosen to feature in the Government's “GREAT for Imagination” campaign.

Read the rest of entry »

Immunocore and MEPC announce significant laboratory expansion at Milton Park in Oxfordshire, UK

Additional space will provide purpose-built research laboratories accommodating around 450 scientists at Immunocore

Read the rest of entry »

Spinning Out Success

OxStem is the largest spin-out company to date to emerge from the University of Oxford's Department of Chemistry.

Read the rest of entry »

Commercializing Cell and Gene Therapies

It takes a commitment to innovation, seamless coordination and the support of an experienced partner to overcome every barrier on the journey from clinical to commercial success.

Read the rest of entry »

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.

OBN Noticeboard

This is an impromptu noticeboard to let people know about events, other things that are happening, perhaps lab equipment for sale etc.  Just drop an email to us, team@obn.org.uk, and we will post.